Literature DB >> 30354363

Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.

Carlo R Bartoli1, David M Zhang2, Samson Hennessy-Strahs1, Jooeun Kang3, David J Restle4, Christian Bermudez1, Pavan Atluri1, Michael A Acker1.   

Abstract

Background Gastrointestinal bleeding from angiodysplasia is a major problem in continuous-flow left ventricular assist device (LVAD) patients. LVAD shear stress causes pathologic degradation of VWF (von Willebrand factor). A mechanistic relationship between VWF degradation and angiodysplasia has not been explored. We tested 2 novel hypotheses: (1) clinical hypothesis: VWF fragments are elevated in LVAD patients that develop angiodysplasia and (2) in vitro hypothesis: VWF fragments generated during LVAD support alter angiogenesis, which may contribute to angiodysplasia. Methods and Results Clinical study: Paired blood samples were collected from continuous-flow LVAD patients (n=35). VWF was quantified with immunoblotting. In vitro experiments: (1) To investigate whether LVAD support alters angiogenesis, human endothelial cells were cultured with LVAD patient plasma (n=11). To investigate mechanism, endothelial cells were cultured with VWF fragments produced by exposing human VWF and ADAMTS-13 (VWF protease) to LVAD-like shear stress (175 dyne/cm2, n=8). Clinical study results: in all patients (n=35, mean support 666±430 days), LVAD support degraded high-molecular-weight VWF multimers ( P<0.0001) into low-molecular-weight VWF multimers ( P<0.0001) and VWF fragments ( P<0.0001). In patients with gastrointestinal bleeding from angiodysplasia (n=7), VWF fragments were elevated ( P=0.02) versus nonbleeders. In contrast, in patients with gastrointestinal bleeding without angiodysplasia, VWF fragments were not elevated versus nonbleeders ( P=0.96). In vitro experiments results: LVAD patient plasma caused abnormal angiogenesis with reduced tubule length ( P=0.04) and migration ( P=0.05). Similarly, endothelial cells grown with VWF degradation fragments exhibited reduced tubule length ( P<0.001) and migration ( P=0.01). Conclusions LVAD patients who bled from angiodysplasia had higher levels of VWF fragments than nonbleeders and gastrointestinal bleeders without angiodysplasia. VWF fragments caused abnormal angiogenesis in vitro. These findings suggest that VWF fragments may be a mechanistic link between LVAD support, abnormal angiogenesis, angiodysplasia, and gastrointestinal bleeding.

Entities:  

Keywords:  angiodysplasia; bleeding; heart assist devices; von Willebrand factor

Mesh:

Substances:

Year:  2018        PMID: 30354363     DOI: 10.1161/CIRCHEARTFAILURE.117.004638

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  12 in total

1.  Risk Stratification of Angioectasia as a Cause of Gastrointestinal Bleeding: Untangling the Spider's Web?

Authors:  Dejan Micic; Neil Sengupta
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

2.  Reinventing the displacement left ventricular assist device in the continuous-flow era: TORVAD, the first toroidal-flow left ventricular assist device.

Authors:  Carlo R Bartoli; Jeffrey R Gohean; Richard W Smalling
Journal:  Ann Cardiothorac Surg       Date:  2021-03

3.  Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management.

Authors:  Carlo R Bartoli
Journal:  Ann Cardiothorac Surg       Date:  2021-05

Review 4.  Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians.

Authors:  Radha Mehta; Muhammad Athar; Sameh Girgis; Atif Hassan; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

5.  Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation.

Authors:  Carlo R Bartoli; Samson Hennessy-Strahs; Robert D Dowling; J William Gaynor; Andrew C Glatz
Journal:  JACC Basic Transl Sci       Date:  2021-03-22

6.  Characterization of a pulsatile rotary total artificial heart.

Authors:  Patrick L Jurney; Jeremy J Glynn; Igor V Dykan; Matthew W Hagen; Sanjiv Kaul; Richard K Wampler; Monica T Hinds; George D Giraud
Journal:  Artif Organs       Date:  2020-10-14       Impact factor: 3.094

7.  Evolving perspectives on mechanical circulatory support biocompatibility and interfaces.

Authors:  Marvin J Slepian; Joseph Italiano; Danny Bluestein; Jawaad Sheriff; Yana Roka-Moiia
Journal:  Ann Cardiothorac Surg       Date:  2021-05

Review 8.  Bionic women and men - Part 1: Cardiovascular lessons from heart failure patients implanted with left ventricular assist devices.

Authors:  Eric J Stöhr; William K Cornwell; Manreet Kanwar; John R Cockcroft; Barry J McDonnell
Journal:  Exp Physiol       Date:  2020-04-03       Impact factor: 2.858

Review 9.  Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review.

Authors:  Srikanth Vedachalam; Gokulakrishnan Balasubramanian; Garrie J Haas; Somashekar G Krishna
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

Review 10.  Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence.

Authors:  Carlotta Sciaccaluga; Nicolò Ghionzoli; Giulia Elena Mandoli; Flavio D'Ascenzi; Marta Focardi; Serafina Valente; Matteo Cameli
Journal:  Biomolecules       Date:  2022-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.